SEC Form D · filed September 27, 2017
Oncternal Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (22)
Olivier Ries · Luxembourg, LuxembourgDirectorThomas A. Roszak · Northfield, ILExecStan Johnson · Fargo, NDDirectorGarheng P. Kong · New Haven, CTDirectorGene Smestad · Valley City, NDExecErin T. Duffy · New Haven, CTExecRay Braun · Valley City, NDDirectorMichael A. Moceri · Chicago, ILDirectorCraig Lloyd · Sioux Falls, SDDirectorKaren J. Jakobi · Irvine, CAExecPaul T. Estrem · New Haven, CTExec · DirectorSteven Kay · San Francisco, CAExecMark Jorgensen · San Francisco, CADirectorDenise Woodard · Jersey City, NJDirectorAllen R. Page · Waxahachie, TXDirectorCalvin E. Webb, Iii · Waxahachie, TXDirectorGayle Troberman · New York, NYDirectorLCM Funds Asset Manager LLC · Milwaukee, WIExecDavid J. Winograd · Milwaukee, WIExec · DirectorDamian Caldwell · Winston-Salem, NCExecRichard Simoni · Palo Alto, CADirectorMichael Krupka · BOSTON, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗